Nucala is a humanized monoclonal antibody that targets human Interleukin-5 (IL-5), it is indicated for add on maintenance treatment of patients 6 years and older with severe asthma with eosinophilic phenotype.
Inflammation is an important component of asthma development. It is mediated by multiple cell types which include eosinophils, a type of white blood cell that protects the body from parasites, allergens and foreign bacteria.
Eosinophilic inflammation can be characterized by high eosinophilic count via bloodwork. IL-5 is a major cytokine which is responsible for eosinophil development.
Nucala binds and targets IL-5 blocking. IL-5 binds to the alpha chain of the IL-5 receptor complex. This prevents IL-5 signaling, reducing the production and survival of eosinophils.
What does Nucala Treat?
Severe asthma and with an eosinophilic phenotype
Chronic rhinosinusitis with nasal polyps (CRSwNP)
Eosinophilic granulomatosis with polyangiitis (EGPA)
Before your infusion, it is important to drink plenty of water and come to your appointment hydrated. Additionally, you must alert us as soon as possible to any changes in your insurance to ensure that we are still an in-network provider for your infusion therapy.
Your dedicated Infusion nurse will check your vitals and review your medical history to check for improvements or potential side effects of your injection.
Your nurse will begin your infusion and check in on you periodically during your treatment.
After your infusion, your nurse will monitor you to ensure you do not have any complications or reactions to the injection.
Why patients choose Pure to receive their Nucala injection
At Pure Infusion Suites®, we create an unmatched patient experience, improve healthcare outcomes and lower the cost of care.
Safe & Private Suites
Comfortable, private rooms with a relaxing, spa-like atmosphere
55” TVs with Netflix, Wifi, drinks, snacks, meals & more